关于：度他雄胺与坦索罗辛联合治疗对有症状的良性前列腺增生男性临床结局的影响：CombAT研究的4年结果。 - Suppr | 超能文献

Re: The Effects of Combination Therapy With Dutasteride and Tamsulosin on Clinical Outcomes in Men With Symptomatic Benign Prostatic Hyperplasia: 4-Year Results From the CombAT Study.

作者信息

Kaplan Steven A

出版信息

J Urol. 2011 Apr;185(4):1384-5. doi: 10.1016/j.juro.2010.12.080. Epub 2011 Feb 19.

DOI:10.1016/j.juro.2010.12.080

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: The Effects of Combination Therapy With Dutasteride and Tamsulosin on Clinical Outcomes in Men With Symptomatic Benign Prostatic Hyperplasia: 4-Year Results From the CombAT Study.关于：度他雄胺与坦索罗辛联合治疗对有症状的良性前列腺增生男性临床结局的影响：CombAT研究的4年结果。

J Urol. 2011 Apr;185(4):1384-5. doi: 10.1016/j.juro.2010.12.080. Epub 2011 Feb 19.

2

The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.度他雄胺和坦索罗辛联合治疗对有症状的良性前列腺增生症男性临床结局的影响：来自 CombAT 研究的 4 年结果。

Eur Urol. 2010 Jan;57(1):123-31. doi: 10.1016/j.eururo.2009.09.035. Epub 2009 Sep 19.

3

The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.基线参数对有症状的良性前列腺增生和前列腺肿大男性使用度他雄胺、坦索罗辛及联合治疗后国际前列腺症状评分变化的影响：CombAT研究的2年数据

Eur Urol. 2009 Feb;55(2):461-71. doi: 10.1016/j.eururo.2008.10.037. Epub 2008 Nov 6.

4

The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study.度他雄胺、坦索罗辛和联合治疗对良性前列腺增生和前列腺增大患者储尿和排尿的影响：阿夫唑嗪和坦索罗辛联合治疗研究的 2 年结果。

Prostate Cancer Prostatic Dis. 2009;12(4):369-74. doi: 10.1038/pcan.2009.37. Epub 2009 Sep 1.

5

Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.联合治疗比单独治疗对前列腺增生（BPH）患者的临床效果：基线特征的 4 年随机、双盲阿夫唑嗪和坦索罗辛联合治疗（CombAT）试验结果。

BJU Int. 2011 Mar;107(6):946-54. doi: 10.1111/j.1464-410X.2011.10124.x. Epub 2011 Feb 18.

6

Re: comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.关于：亚洲和白种人良性前列腺增生男性患者治疗反应的比较：度他雄胺与坦索罗辛联合研究的长期结果

J Urol. 2014 Feb;191(2):423-4. doi: 10.1016/j.juro.2013.10.088. Epub 2013 Oct 24.

7

Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.亚洲和高加索男性良性前列腺增生症治疗反应的比较：度他雄胺和坦索罗辛联合治疗的长期结果研究。

Int J Urol. 2012 Nov;19(11):1031-5. doi: 10.1111/j.1442-2042.2012.03091.x. Epub 2012 Jul 9.

8

[Comment to: «Cost-Effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain»].[对《度他雄胺与坦索罗辛联合治疗西班牙良性前列腺增生症的成本效益》的评论]

Actas Urol Esp. 2011 Feb;35(2):72. doi: 10.1016/j.acuro.2010.12.002. Epub 2011 Feb 15.

9

Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK.英国良性前列腺增生患者中单剂量坦索罗辛和度他雄胺联合治疗与坦索罗辛单药治疗的成本效益比较。

BJU Int. 2013 Sep;112(5):638-46. doi: 10.1111/j.1464-410X.2012.11659.x. Epub 2013 Jan 28.

10

Dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic enlargement.度他雄胺/坦索罗辛固定剂量复方制剂用于治疗良性前列腺增生。

Drugs Today (Barc). 2012 Jan;48(1):17-24. doi: 10.1358/dot.2012.48.1.1729392.

引用本文的文献

1

Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients.锯叶棕果实的正己烷提取物与坦索罗辛治疗中重度 LUTS-BPH 患者的疗效和耐受性比较。

Sci Rep. 2021 Sep 29;11(1):19401. doi: 10.1038/s41598-021-98586-5.

2

Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials.睾酮替代疗法对性腺功能减退男性的疗效与安全性：一项安慰剂对照试验的荟萃分析研究

Exp Ther Med. 2016 Mar;11(3):853-863. doi: 10.3892/etm.2015.2957. Epub 2015 Dec 23.